Ardent Health, Inc. earnings per share and revenue
On Nov 12, 2025, ARDT reported earnings of 0.52 USD per share (EPS) for Q3 25, beating the estimate of 0.41 USD, resulting in a 24.85% surprise. Revenue reached 1.58 billion, compared to an expected 1.58 billion, with a -0.11% difference. The market reacted with a -33.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 analysts forecast an EPS of 0.31 USD, with revenue projected to reach 1.66 billion USD, implying an decrease of -40.38% EPS, and increase of 5.52% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
What were Ardent Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Ardent Health, Inc. reported EPS of $0.52, beating estimates by 24.85%, and revenue of $1.58B, -0.11% below expectations.
How did the market react to Ardent Health, Inc.'s Q3 2025 earnings?
The stock price moved down -33.81%, changed from $14.05 before the earnings release to $9.30 the day after.
When is Ardent Health, Inc. expected to report next?
The next earning report is scheduled for Mar 04, 2026.
What are the forecasts for Ardent Health, Inc.'s next earnings report?
Based on 14
analysts, Ardent Health, Inc. is expected to report EPS of $0.31 and revenue of $1.66B for Q4 2025.